Topics

Companies Related to "Naloxone injection opioid overdose approved" [Most Relevant Company Matches] RSS

23:02 EST 10th December 2019 | BioPortfolio

Here are the most relevant search results for "Naloxone injection opioid overdose approved" found in our extensive corporate database of over 50,000 company records.

Showing "Naloxone injection opioid overdose approved" Companies 1–25 of 788

Extremely Relevant

The Opioid Center of Support

Vera Bullock founded The Opioid Center of Support to develop solutions to the opioid crisis for caregivers. After her son Justin Solak died from an opioid overdose at the age of 25, Vera set out with a mission to help others suffering with a loved one coping with misuse. Having personally experienced the frustration of trying to find credible resources to ...


Reckitt Benckiser Pharmaceuticals Inc.

Reckitt Benckiser Pharmaceuticals Inc. is a specialty pharmaceutical company that markets SUBOXONE(R) (buprenorphine HCl/naloxone HCl dihydrate [2 mg/0.5 mg and 8 mg/2 mg]) C-III Sublingual Tablets and SUBUTEX(R) (buprenorphine HCl [2 mg and 8 mg]) C-III Sublingual Tablets, formulations of buprenorphine used to treat opioid dependence in a medical office-based setting. SUBOXONE(R) and SUBUTEX(R),...

Relevant

Acura Pharmaceuticals

Acura Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on research and development of our proprietary Aversion® (abuse deterrent) Technology and related product candidates. Aversion® Technology can be formulated into orally administered tablets or capsules containing active pharmaceutical ingredients including oxycodone, hydrocodone, hydromorphone, oxymorphone, morphine, code...


Ensysce Biosciences, Inc.

Ensysce Biosciences, San Diego, CA, is an integrated drug delivery company for both small and large molecules. To overcome the major problem of non-medical use of opioid products, Ensysce is using its prodrug technology to improve abuse deterrent properties. The BIO-MD™ prodrug abuse deterrent and MPAR™ overdose resistant pain platforms, with wor...

Connecticut Opioid Strategy Taskforce

The Connecticut Opioid Strategy Taskforce (COST) is a bipartisan coalition of municipal stakeholders advocating for legislation that will allow Connecticut municipalities to seek damages from corporations involved in the manufacture and distribution of the pharmaceuticals that are fueling the current opioid crisis in their communities. To learn more or to ...

Priska

Priska™ is designed to provide assessment data associated with a patient’s risk for opioid abuse, as well as other mental health conditions. The Opioid Risk Tool assessment consists of a 5-question survey and fits each patient into one of three risk categories: low risk, moderate risk or high risk. The peer-reviewed tool is highly trusted and wid...

Lightlake Therapeutics Inc

Lightlake Therapeutics is an early stage biopharmaceutical company aiming to build a solid platform of pharmacological treatments based on our expertise using opioid antagonists. Other significant developments include the use of an opioid antagonist nasal spray to address binge-eating obesity. A Phase II trial of this product in Helsinki is due to be compl...

Lightlake Therapeutics Inc.

Lightlake Therapeutics is an early stage biopharmaceutical company aiming to build a solid platform of pharmacological treatments based on our expertise using opioid antagonists. Other significant developments include the use of an opioid antagonist nasal spray to address binge-eating obesity. A Phase II trial of this product in Helsinki is due to be compl...

GTC Biotherapeutics

GTC Biotherapeutics develops, produces, and commercializes therapeutic proteins using transgenic animal technology. ATryn®, recombinant human antithrombin, is the first transgenically produced therapeutic protein approved anywhere in the world, having recently been approved by the European Commission (EMEA) for the prophylactic treatment of deep vein thrombosis in patients with hereditary antith...

Techpool Bio-pharma Co., Ltd.

Established in 1993, Techpool Bio-Pharma Co., Ltd. is one of the leading bio-pharma companys in China, with total assets of USD30 million and registered capital of USD11.7 million. We are specializing in R&D, manufacturing and marketing of bio-pharmaceutical products and currently export to Japan, Korea, India, Pakistan, Israel etc. We manufacture the following pharmaceutical products: Finished p...

Sure Med Compliance

Sure Med Compliance has a vision of ending the opioid epidemic through greater prescribing compliance. This is achieved through training, chart auditing, software integration and providing physicians with a written diversion control plan. In a short period of time, Sure Med Compliance has made a big impact on prescribing habits in the Southeast United Stat...

Tremeau Pharmaceuticals, Inc.

Tremeau is a new pharmaceutical company focused on providing non-opioid treatment options for rare diseases and other unique patient conditions with no approved treatments. Tremeau’s unique approach to acute and chronic pain in rare diseases is rooted in the mechanism of action, documented efficacy, and clinically differentiated profile of COX-2 selec...

CleanSlate Centers

A pioneer and leader in outpatient addiction medicine, CleanSlate Centers is a national medical group which provides treatment for the chronic disease of addiction, primarily opioid and alcohol use disorders. Founded in 2009 in response to the growing opioid epidemic facing the country, the company operates a growing network of physician-led, office-based ...

Charleston Laboratories, Inc.

Charleston Laboratories Inc, headquartered in Charleston, SC, is a privately funded specialty pharmaceutical company developing and commercializing opioid drugs with minimal or no opioid-induced nausea and vomiting (OINV). Charleston Laboratories intends to enter into discovery and commercialization alliances with partners motivated to introduce novel pain therapies that eliminate or significant...

Neumentum

Neumentum is developing and plans to commercialize products that have the potential to effectively treat pain, without the risks of abuse, misuse and diversion seen with opioid analgesics. Neumentum’s lead product candidate, NTM-001 (novel, alcohol-free formulation of ketorolac in a pre-mixed bag for continuous IV infusion), has the potential to treat...

Cytogen

Cytogen is a specialty pharmaceutical company dedicated to advancing the treatment and care of cancer patients by building, developing, and commercializing a portfolio of oncology products. The Company's specialized sales force currently markets QUADRAMET® (samarium Sm-153 lexidronam injection), PROSTASCINT® (capromab pendetide), and SOLTAMOX™ (tamoxifen citrate) to the U.S. oncology market. Q...

Neumentum Inc.

Neumentum is developing and plans to commercialize products that have the potential to effectively treat pain, without the risks of abuse, misuse and diversion seen with opioid analgesics. Neumentum’s lead product candidate, NTM-001 (novel, alcohol-free formulation of ketorolac in a pre-mixed bag for continuous IV infusion), has the potential to treat moderately severe acute pain that requir...

Minnesota Adult and Teen Challenge

The Ramsey County Coalition is hosting a press conference to announce details of its “Not Another Overdose” campaign, which will include prevention events, community messaging and a PSA that will be shown at local movie theaters.

Ypsomed AG

Our name reflects our expertise: “ipso” means “self” and “med” stands for medication. Hence our company name perfectly illustrates our core business: to market products and services which allow patients to administer their own medication in a safe, simple way. Our self-injection devices and our support and advisory services help millions of people, most of them diabetics, to enjoy the ...

QOL Medical, LLC

QOL Medical, LLC, based in Vero Beach, is a specialty biopharmaceutical company focused on pediatric products for genetic and rare orphan diseases. QOL invests in clinical stage and marketed products and currently markets 2 approved products: Sucraid (sacrosidase) Oral Solution for Congenital Sucrase-Isomaltase Deficiency and Ethamolin (Ethanolamine Oleate...

Vapogenix

Vapogenix, based in Houston, TX, is a clinical stage company developing a new class of topical, non-opioid analgesics to alleviate pain. While most pain is localized, most pain medications are administered orally, which often results in systemic side effects. Vapogenix is focused on treating pain locally – at its source. The Company’s products are volatile anesthetics (VAs) formulated f...

Contura Inc.

Aquamid is composed of 97.5% water for injection and 2.5% cross-linked polyacrylamide. The patented hydrogel is homogeneous: it contains no micro particles; hence its filling effect is due solely to the injected volume. Unlike particle-based fillers, the hydrogel does not rely on an intended foreign body reaction to achieve the desired augmentation. Therefore, the filling effect is immediate and p...

Journal of Opioid Management

Advocates for Opioid Recovery

Pharmacia Biotech Incorporated

Pharmacia is a top-tier global pharmaceutical company, with a leading agricultural subsidiary. Pharmacia have built a portfolio of outstanding products, led by key growth drivers: CELEBREX® (celecoxib capsules), CAMPTOSAR® (irinotecan hydrochloride injection), XALATAN® (latanoprost ophthalmic solution), DETROL®LA (tolterodine tartrate extended release capsules), and ZYVOX™ (linezolid injecti...


More From BioPortfolio on "Naloxone injection opioid overdose approved"

Quick Search

Corporate Database Quicklinks